REQUEST A DEMO
Total
USD $0.00
Search more companies

Asklepios Cure Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Toilet Preparation Manufacturing | Navigational, Measuring, Electromedical, and Control Instruments Manufacturing | All Other Miscellaneous Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Department Stores | Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Asklepios Cure Sp. z o.o. Profile Updated: October 02, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Asklepios Cure Sp. z o.o. is based in Poland, with the head office in Poznan. The company operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on February 17, 2021. A negative growth of 0.27% was recorded in its total assets.

Headquarters
Ul. Adama Mickiewicza 5/7
Poznan; Wielkopolskie; Postal Code: 60-833

Contact Details: Purchase the Asklepios Cure Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Asklepios Cure Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Asklepios Cure Sp. z o.o. report to view the information.
Incorporation Date:
February 17, 2021
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Asklepios Cure Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
99.3%
Net Profit (Loss) for the Period
99.3%
Total assets
-0.27%
Total equity
-0.14%
Return on Equity (ROE)
-20.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?